We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWKN icon
9651
CALL
Hawkins
HWKN
$2.75B
$294K ﹤0.01%
2,400
-1,500
-38% -$189K
MZTI
9652
PUT
The Marzetti Company
MZTI
$3.15B
$294K ﹤0.01%
1,700
-600
-26% -$110K
MPRO icon
9653
Monarch ProCap Index ETF
MPRO
$258M
$294K ﹤0.01%
+10,287
New +$304K
WKHS icon
9654
CALL
Workhorse Group
WKHS
$36.1M
$294K ﹤0.01%
2,811
+2,264
+414% +$309K
SOXQ icon
9655
PUT
Invesco PHLX Semiconductor ETF
SOXQ
$3.03B
$294K ﹤0.01%
7,500
-3,800
-34% -$152K
IPAY icon
9656
Amplify Mobile Payments ETF
IPAY
$183M
$294K ﹤0.01%
+5,073
New +$291K
CMPR icon
9657
CALL
Cimpress
CMPR
$2.23B
$294K ﹤0.01%
4,100
-200
-5% -$15.7K
ESNT icon
9658
PUT
Essent Group
ESNT
$6.24B
$294K ﹤0.01%
5,400
-1,800
-25% -$104K
ORIC icon
9659
Oric Pharmaceuticals
ORIC
$1.39B
$294K ﹤0.01%
36,426
+30,659
+532% +$281K
MREO
9660
CALL
Mereo BioPharma
MREO
$49.1M
$294K ﹤0.01%
83,900
+67,200
+402% +$264K
AMPH icon
9661
PUT
Amphastar Pharmaceuticals
AMPH
$887M
$293K ﹤0.01%
7,900
+4,400
+126% +$201K
UTI icon
9662
PUT
Universal Technical Institute
UTI
$1.44B
$293K ﹤0.01%
11,400
-7,200
-39% -$150K
XPRO icon
9663
PUT
Expro Ltd
XPRO
$2.09B
$293K ﹤0.01%
23,500
+7,700
+49% +$107K
BIB icon
9664
ProShares Ultra NASDAQ Biotechnology
BIB
$90.1M
$293K ﹤0.01%
5,784
+3,892
+206% +$231K
PL icon
9665
CALL
Planet Labs
PL
$8.69B
$293K ﹤0.01%
72,500
+11,100
+18% +$34.5K
CORN icon
9666
PUT
Teucrium Corn Fund
CORN
$168M
$293K ﹤0.01%
15,600
-15,000
-49% -$272K
APRW icon
9667
AllianzIM U.S. Equity Buffer20 Apr ETF
APRW
$201M
$293K ﹤0.01%
8,917
-2,314
-21% -$75.6K
SCHH icon
9668
PUT
Schwab US REIT ETF
SCHH
$11.3B
$293K ﹤0.01%
13,900
-4,400
-24% -$98.3K
ULTY icon
9669
PUT
YieldMax Ultra Option Income Strategy ETF
ULTY
$768M
$292K ﹤0.01%
3,260
+930
+40% +$92.9K
DON icon
9670
WisdomTree US MidCap Dividend Fund
DON
$4.11B
$292K ﹤0.01%
+5,732
New +$301K
FAPR icon
9671
FT Vest US Equity Buffer ETF April
FAPR
$1.31B
$292K ﹤0.01%
7,074
-8,453
-54% -$346K
CCSO icon
9672
Carbon Collective Climate Solutions US Equity ETF
CCSO
$49.6M
$292K ﹤0.01%
14,384
+3,993
+38% +$84.1K
INMB icon
9673
CALL
INmune Bio
INMB
$59.1M
$292K ﹤0.01%
62,500
+33,200
+113% +$173K
HYEM icon
9674
VanEck Emerging Markets High Yield Bond ETF
HYEM
$521M
$292K ﹤0.01%
+14,988
New +$294K
IRMD icon
9675
iRadimed
IRMD
$1.13B
$292K ﹤0.01%
+5,304
New +$279K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.